The PanOmics TargetID Framework – a modular system designed to assist clients in achieving their R&D goals – is an integral part of Evotec’s drug discovery program. PanOmics is the overarching term used to refer to the analysis of multiple data sets obtained from clinical studies and related biomedical sources. The TargetID Framework uses computational tools coupled with expert assessments to identify and rank potential drug targets based on their disease-relevance, druggability, biology, safety, competition, and efficacy. Being fully integrated into Evotec's drug discovery pipeline, it enables the client to leverage additional work packages and/or omics data, to aid the transition from target identification to IND. Download our whitepaper to find out more - https://hubs.ly/Q02dfwLB0 #researchneverstops
CRISPR-Select may help in Target Validation